Improving Outcomes in Medically Underserved and Rural Areas

Susan G. Komen is taking leadership again today in the breast cancer movement with the announcement of a new, multi-year partnership with GE.  Komen Founder and CEO Ambassador Nancy G. Brinker and GE chairman and CEO Jeff Immelt announced the partnership today, aimed at bringing new technology and innovation to the breast cancer movement to dramatically improve breast cancer outcomes for women in rural areas and developing countries.

In the U.S., the Komen/GE partnership will start with screening initiatives for Wyoming, one of the least densely populated regions of the country, and to Saudi Arabia and China, with an aim of overcoming medical resource and education issues that may affect screening rates.

GE also announced a $1 billion cancer research and development commitment, and a $100 million innovation challenge to find and fund ideas for better breast cancer diagnostics.

Today’s partnership announcement follows our announcement Tuesday of a new partnership with the George W. Bush Institute, the U.S. State Department and UNAIDS to bring breast and cervical cancer screening to existing HIV/AIDS platforms in Africa. That program is called the Pink Ribbon, Red Ribbon partnership.

Read more over at the GE Healthymagination Blog.

About the author

Susan G. Komen has written 342 articles for Susan G. Komen® | Blog

Nancy G. Brinker promised her dying sister, Susan G. Komen, she would do everything in her power to end breast cancer forever. In 1982, that promise became Susan G. Komen and launched the global breast cancer movement. Today, Komen is the world’s largest grassroots network of breast cancer survivors and activists fighting to save lives, empower people, ensure quality care for all and energize science to find the cures. Thanks to events like the Komen Race for the Cure®, we have invested more than $1.9 billion to fulfill our promise, becoming the largest source of nonprofit funds dedicated to the fight against breast cancer in the world.

There are no responses so far.

New comments are closed.